Türkiye Change Country

KCI and YHEC Launch Flexible New Evidence-based Tool to Help Hospitals Optimize Pressure Ulcer Treatment Strategies

Released : 20 Mayıs 2009

Kinetic Concepts, Inc. in conjunction with The York Health Economics Consortium (YHEC) will launch a new Budget Impact Model (BIM) for wound care surfaces at the European Wound Management Association (EWMA) Conference in Helsinki .

HELSINKI, FINLAND -- May 20, 2009 — Kinetic Concepts, Inc. in conjunction with The York Health Economics Consortium (YHEC) will launch a new Budget Impact Model (BIM) for wound care surfaces at the European Wound Management Association (EWMA) Conference in Helsinki .

The economic modeling tool, which will be presented internationally for the first time by YHEC staff during the May 21st KCI symposium Pressure ulcer prevention: prevalence and incidence in context , helps centers determine cost, reduce incidence and optimize treatment mix.

The first step in using the BIM tool allows individual centers to easily see how much they spend on pressure ulcer management in the at risk population. “Based on the size of the hospital (number of beds) and the number of admissions, the Budget Impact Model generates an estimate of the number of ulcers that are likely to occur in any year and their associated treatment costs,” explains Paul Trueman, Director, YHEC.

“It also uses evidence from an authoritative study1 into the annual cost of treating pressure ulcers that NICE (the UK 's National Institute for Health and Clinical Excellence) also used for its cost modeling. Just how much a center is spending on pressure ulcer management can often come as a shock to hospital managers. Treatment of ulcers occurring from admissions to a typical 500 bed hospital can easily amount to €20 million per year if steps are not put in place to help prevent the development of ulcers and manage them appropriately when they occur.”

The next step assists centers with developing measures to reduce the incidence of pressure ulcers. Documented facility case studies show that replacing standard foam mattresses with KCI's AtmosAir™ family of surfaces, featuring self-adjusting pressure technology, helps reduce the development of pressure ulcers.

The third use of the modeling tool helps centers review their overall pressure ulcer management strategy and optimize their treatment mix so they use the right products for the right indications for the appropriate length of therapy. The BIM provides transparency to ensure proper decisions impacting patient care and facility economics can be reviewed regularly.

The flexibility of the wound care surfaces BIM means it can be tailored to specific economic needs of each country's health system. The tool is presently available for use in the UK . A US version will be available in early Q3 2009 followed by customized versions for Austria , Canada , Germany and other countries in late 2009.

“As a global leader in therapeutic support systems, KCI is well positioned to help hospitals optimize their pressure ulcer treatment strategies, both clinically and financially,” said Lynne Sly, Global President Therapeutic Support Systems. “With the combination of our broad portfolio of therapy options and positive clinical outcomes, we can help hospitals achieve their patient care and financial goals.” Sly added, “The wound care surfaces Budget Impact Model is an important extension of our ongoing partnership between KCI and YHEC that continues to benefit hospitals, clinicians and, most important of all, patients around the world.”

“YHEC works with specialist medical suppliers, like KCI, as well as healthcare payer and provider organizations,” said Trueman, “to support hospitals and health services in identifying and delivering the best possible care strategies within the budgets available to them. The appropriate allocation of healthcare funds is even more important than ever, in light of the current economic pressures.”

The new BIM for wound care surfaces addresses a major issue for health services globally. In the UK for example, NHS research shows that the annual total spend on pressure ulcer management is currently between ₤1.8 and ₤2.6 billion per year2. Most developed countries have ageing populations resulting in a growing proportion of hospital patients ‘at risk' of developing pressure ulcers. By using the BIM, hospitals have the potential to significantly reduce their costs in treating pressure ulcers. The potential savings hospitals stand to make from the wise application of this BIM are significant.

About KCI

Kinetic Concepts, Inc. (NYSE: KCI) is a leading global medical technology company devoted to the discovery, development, manufacture and marketing of innovative, high-technology therapies and products for the wound care, tissue regeneration and therapeutic support system markets. Headquartered in San Antonio , Texas , KCI's success spans more than three decades and can be traced to a history deeply rooted in innovation and a passion for significantly improving the healing and the lives of patients around the world.

KCI's three primary businesses are:

Advanced Wound Care - Includes KCI's proprietary Vacuum Assisted Closure ® , or V.A.C. ® Therapy System, which has been clinically demonstrated to promote wound healing through unique mechanisms of action while reducing the overall cost of treating patients with complex wounds.

Regenerative Medicine - Represented by KCI's LifeCell business and includes tissue-based products for use in reconstructive, orthopedic and urogynecologic surgical procedures to repair soft tissue defects.

Therapeutic Support Systems - Includes specialty hospital beds, mattress replacement systems and overlays designed to address pulmonary complications associated with immobility, to reduce skin breakdown and assist caregivers in the safe and dignified handling of patients of size.

The Company employs approximately 6,700 people and markets its products in more than 20 countries. For more information about KCI, and how its products are changing the practice of medicine, visit www.KCI1.com .

About York Health Economics Consortium

The York Health Economics Consortium (YHEC) at the University of York was established in 1986 in recognition of the increasing application of economic principles to healthcare, with the intention of providing economic support to organizations within the National Health Service.

YHEC's work in health technology assessment has expanded rapidly due to demand from the pharmaceutical and medical device sectors. The consortium has long-standing relationships with a number of global pharmaceutical companies, having developed analyses to support pricing, reimbursement and market access throughout Europe and beyond. YHEC also has extensive experience of working with medical device manufacturers and understands the challenges that occur in the development of rapidly evolving technologies.

YHEC is entirely owned by the University of York and remains a constituent part of the university health and social research departments which include the Centre for Health Economics, the Centre for Reviews & Dissemination and the Department of Health Sciences. YHEC frequently collaborates with these departments, as well as other health related research departments and the Hull/York Medical School.

FOR MORE INFORMATION, CONTACT:

Kinetic Concepts, Inc.
Media Relations:
Media@kci1.com for journalists only.
or
Investors Relations:
IR@kci1.com for Investor Relations inquiries.

1. Bennett G, Dealey C, Posnett J. The cost of pressure ulcers in the UK . Age and Ageing 2004; 33: 230-235.
2. Posnett J, Franks PJ. The burden of wounds in the UK , Nursing Times, Jan 22-28; 104(3): 44-5.
 


Hastalara Yönelik Önemli Mesaj

Yasal Uyarı | Gizlilik Politikası | Bize Ulaşın


Telif Hakkı © 1998 – 2013 KCI Licensing, Inc Tüm Hakları Saklıdır.     DSL#12-0298.TR
Bu Web sitesinde yer alan bilgiler yalnızca Türkiye'de görüntülenecek şekilde ve bu amaçla hazırlanmışlardır. Bu Web sitesi, farklı ülkelerde bulunan veya bulunmayan ve mümkünse, farklı ülkelerde farklı göstergeler ve sınırlamalar için bir düzenleyici makam tarafından onay veya izin almış ya da almamış olan ürünler hakkında bilgiler içerir.